MDT241129P105000
- 0.00
- 0.000.00%
Medtronic Newsroom
10 Health Care Stocks With Whale Alerts In Today's Session
Medtronic Reports Outcomes From Aortic Stenosis Treatment Study of TAVR System
Trump 2.0: Who Are Potential Tax-cut Beneficiaries?
Reasons to Retain Medtronic Stock in Your Portfolio Now
Wednesday Ends With Index Decline | Wall Street Today
Canada Diabetes Devices Market Forecast Report and Company Analysis 2024-2032, Featuring Novo Nordisk, Eli Lilly, Roche, Abbott, Dexcom, Medtronic, Terumo, Ypsomed
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
FDA Approves Medtronic InPen App, Launching Smart MDI System With Simplera CGM
Press Releases
Medtronic | 10-Q: Q2 2025 Earnings Report
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Medtronic Evolut Pro TAVR Demonstrates Positive Outcomes in Study
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Starbucks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Medtronic Analyst Ratings
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $109
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $109
Unusual Options Activity: SPOT, MOD and Others Attract Market Bets, SPOT V/OI Ratio Reaches 90.4
With 85% Institutional Ownership, Medtronic Plc (NYSE:MDT) Is a Favorite Amongst the Big Guns
Barclays Adjusts Price Target on Medtronic to $109 From $105